SEC 13F Intelligence

Sivik Global Healthcare LLC / TMO

Sivik Global Healthcare LLC’s Thermo Fisher Scientific Inc Position

Does Sivik Global Healthcare LLC own Thermo Fisher Scientific Inc (TMO)? Yes8.0K shares worth $4M (+2.99% of its 13F portfolio) as of Q1 2026, down from 12.0K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
8.0K
% of Portfolio
+2.99%
Quarters Held
25
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $5MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $6MQ4 ’19Q1 ’20: $4MQ2 ’20: $4MQ3 ’20: $9MQ4 ’20: $7MQ4 ’20Q1 ’21: $8MQ3 ’21: $5MQ4 ’21: $8MQ1 ’22: $7MQ1 ’22Q2 ’22: $7MQ3 ’22: $8MQ4 ’22: $6MQ1 ’23: $6MQ1 ’23Q2 ’23: $4MQ3 ’23: $5MQ4 ’23: $6MQ1 ’24: $9MQ1 ’24Q2 ’24: $8MQ3 ’25: $7MQ4 ’25: $7MQ1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20268.0K$4M+2.99%
Q4 202512.0K$7M+2.02%
Q3 202514.0K$7M+1.98%
Q2 202414.0K$8M+2.78%
Q1 202415.5K$9M+2.11%
Q4 202312.0K$6M+2.66%
Q3 202310.5K$5M+2.69%
Q2 20237.5K$4M+0.92%
Q1 202311.0K$6M+2.73%
Q4 202211.0K$6M+2.85%
Q3 202215.0K$8M+4.23%
Q2 202212.5K$7M+3.86%
Q1 202212.5K$7M+3.05%
Q4 202112.5K$8M+3.57%
Q3 202115.0K$5M+1.28%
Q1 202117.5K$8M+2.91%
Q4 202015.0K$7M+2.85%
Q3 202020.0K$9M+3.80%
Q2 2020106.1K$4M+1.34%
Q1 2020100.0K$4M+1.42%
Q4 201917.5K$6M+2.11%
Q3 201915.0K$4M+2.20%
Q2 201915.0K$4M+1.07%
Q1 201920.0K$5M+2.02%
Q4 201815.0K$3M+1.81%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of TMO.